RxDoctor Payments Data

Olajide Fawehinmi, MD

Psychiatry · Pittsfield, MANPI 1639518780

Payments from drug & device makers

$1,158in general payments, 2019–2025

Across 61 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$513
  • Corium, LLC$138
  • Takeda Pharmaceuticals U.S.A., Inc.$122
  • Lundbeck LLC$106
  • Shire North American Group Inc$69
  • Neos Therapeutics, LP$56
  • plus $155 from 6 others

What the payments were for

  • Food & beverage$1,158100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,158 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$45,074
Medicare patients
50
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate13$43,421
Lisdexamfetamine Dimesylate17$2,996
TrintellixVortioxetine Hydrobromide12$2,738
Mirtazapine31$1,656
Quetiapine Fumarate68$1,506
Bupropion XlBupropion Hcl33$1,080
Olanzapine26$1,080
Hydroxyzine Hcl52$988
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$944
Buspirone Hcl80$761
Duloxetine Hcl41$757
Gabapentin61$609
Aripiprazole34$540
Trazodone Hcl53$519
Divalproex Sodium18$491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$122$2,73812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Pittsfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →